These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Thyroid receptor ligands. 1. Agonist ligands selective for the thyroid receptor beta1. Ye L; Li YL; Mellström K; Mellin C; Bladh LG; Koehler K; Garg N; Garcia Collazo AM; Litten C; Husman B; Persson K; Ljunggren J; Grover G; Sleph PG; George R; Malm J J Med Chem; 2003 Apr; 46(9):1580-8. PubMed ID: 12699376 [TBL] [Abstract][Full Text] [Related]
3. Thyroid hormone analogues. Synthesis of 3'-substituted 3,5-diiodo-L-thyronines and quantitative structure-activity studies of in vitro and in vivo thyromimetic activities in rat liver and heart. Leeson PD; Ellis D; Emmett JC; Shah VP; Showell GA; Underwood AH J Med Chem; 1988 Jan; 31(1):37-54. PubMed ID: 3336030 [TBL] [Abstract][Full Text] [Related]
4. Acute effects of thyroid hormone analogs on sodium currents in neonatal rat myocytes. Huang CJ; Geller HM; Green WL; Craelius W J Mol Cell Cardiol; 1999 Apr; 31(4):881-93. PubMed ID: 10329215 [TBL] [Abstract][Full Text] [Related]
5. alpha-Methylated analogues of triiodothyroalkanoic acids: synthesis and biological activity. Zenker N; Ekpe AE; Hubbard LS J Med Chem; 1992 Feb; 35(3):548-52. PubMed ID: 1738147 [TBL] [Abstract][Full Text] [Related]
6. Role of iodine in thyroid hormones: molecular conformation of a halogen-free hormone analogue. Cody V J Med Chem; 1980 May; 23(5):584-7. PubMed ID: 7381861 [TBL] [Abstract][Full Text] [Related]
7. Thyromimetics: a review of recent reports and patents (2004 - 2009). Hirano T; Kagechika H Expert Opin Ther Pat; 2010 Feb; 20(2):213-28. PubMed ID: 20100003 [TBL] [Abstract][Full Text] [Related]
9. Beneficial effects of a novel thyromimetic on lipoprotein metabolism. Taylor AH; Stephan ZF; Steele RE; Wong NC Mol Pharmacol; 1997 Sep; 52(3):542-7. PubMed ID: 9281617 [TBL] [Abstract][Full Text] [Related]
11. Thyroid receptor ligands. Part 2: Thyromimetics with improved selectivity for the thyroid hormone receptor beta. Hangeland JJ; Doweyko AM; Dejneka T; Friends TJ; Devasthale P; Mellström K; Sandberg J; Grynfarb M; Sack JS; Einspahr H; Färnegårdh M; Husman B; Ljunggren J; Koehler K; Sheppard C; Malm J; Ryono DE Bioorg Med Chem Lett; 2004 Jul; 14(13):3549-53. PubMed ID: 15177471 [TBL] [Abstract][Full Text] [Related]
12. Discovery of a novel series of 6-azauracil-based thyroid hormone receptor ligands: potent, TR beta subtype-selective thyromimetics. Dow RL; Schneider SR; Paight ES; Hank RF; Chiang P; Cornelius P; Lee E; Newsome WP; Swick AG; Spitzer J; Hargrove DM; Patterson TA; Pandit J; Chrunyk BA; LeMotte PK; Danley DE; Rosner MH; Ammirati MJ; Simons SP; Schulte GK; Tate BF; DaSilva-Jardine P Bioorg Med Chem Lett; 2003 Feb; 13(3):379-82. PubMed ID: 12565933 [TBL] [Abstract][Full Text] [Related]
13. 3'-Acetyl-3,5-diiodo-L-thyronine: a novel highly active thyromimetic with low receptor affinity. Benson MG; Ellis D; Emmett JC; Leeson PD; Pearce NJ; Shah VP; Underwood AH Biochem Pharmacol; 1984 Oct; 33(20):3143-9. PubMed ID: 6091671 [TBL] [Abstract][Full Text] [Related]
14. An activator protein-1 (AP-1) response element on pro alpha1(l) collagen gene is necessary for thyroid hormone-induced inhibition of promoter activity in cardiac fibroblasts. Lee HW; Klein LE; Raser J; Eghbali-Webb M J Mol Cell Cardiol; 1998 Nov; 30(11):2495-506. PubMed ID: 9925384 [TBL] [Abstract][Full Text] [Related]
15. Analysis of the binding of 3,3',5-triiodo-L-thyronine and its analogues to mutant human beta 1 thyroid hormone receptors: a model of the hormone binding site. Cheng SY; Ransom SC; McPhie P; Bhat MK; Mixson AJ; Wintraub BD Biochemistry; 1994 Apr; 33(14):4319-26. PubMed ID: 8155649 [TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationships of milrinone analogues determined in vitro in a rabbit heart membrane Ca(2+)-ATPase model. Cody V; Wojtczak A; Davis FB; Davis PJ; Blas SD J Med Chem; 1995 May; 38(11):1990-7. PubMed ID: 7783130 [TBL] [Abstract][Full Text] [Related]
17. Thyromimetics: a journey from bench to bed-side. Tancevski I; Rudling M; Eller P Pharmacol Ther; 2011 Jul; 131(1):33-9. PubMed ID: 21504761 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and structure-activity studies of N,N'-diarylguanidine derivatives. N-(1-naphthyl)-N'-(3-ethylphenyl)-N'-methylguanidine: a new, selective noncompetitive NMDA receptor antagonist. Reddy NL; Hu LY; Cotter RE; Fischer JB; Wong WJ; McBurney RN; Weber E; Holmes DL; Wong ST; Prasad R J Med Chem; 1994 Jan; 37(2):260-7. PubMed ID: 8295213 [TBL] [Abstract][Full Text] [Related]
19. Thyroid hormone action on liver, heart, and energy expenditure in thyroid hormone receptor beta-deficient mice. Weiss RE; Murata Y; Cua K; Hayashi Y; Seo H; Refetoff S Endocrinology; 1998 Dec; 139(12):4945-52. PubMed ID: 9832432 [TBL] [Abstract][Full Text] [Related]
20. A new class of high affinity thyromimetics containing a phenyl-naphthylene core. Hangeland JJ; Friends TJ; Doweyko AM; Mellström K; Sandberg J; Grynfarb M; Ryono DE Bioorg Med Chem Lett; 2005 Oct; 15(20):4579-84. PubMed ID: 16099653 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]